The committee suggests these possible topics:
- Assessing mental health and substance abuse treatment needs
- Making successful referrals to mental health, substance abuse, and oral health services
- The importance of oral health services
- Bridging diagnosis and treatment
- Practices promoting successful care teams – integrated roles
- Using peer navigators/advocates
- When to start treatment, what to start with
- Treatment options for treatment naive/treatment experienced
- Salvage treatment
- Resistance testing (advanced/beginner)
- New ARVs
- Pharmacogenomics and investigational ARVs
- Long term effects of HAART
- Medical case management
- Sequencing existing ARV regimens
- Benefits of investigational drugs over current arsenal
- Aging and HIV issues
- Neurocognitive complications/disorders
- Changes in federal treatment guidelines
- Maternal child transmission
- Drug-drug interactions
- HPV infection and HIV risk
- HSV and HIV risk
- Treatment de-intensification
- Determining therapeutic efficacy, failure or toxicity
- Treatment as prevention/ test and treat models and implications for both treatment and prevention
- Novel treatments
- HIV pathogenesis (beginner and advanced)
- Strategies for administering ARVs to simplify treatment, avoid toxicity and increase convenience
- Metabolic syndromes – diabetes
- Kidney disease
- Liver failure
- Bone disorders/bone density
- Anal cancer in men who have sex with men
- Inflammation and HIV
- Resistance
- Adherence strategies
- Cardiovascular complications
- Access to care and treatment
- Retention in care and treatment
- Post incarcerated care
- Liver transplantation and HIV
- What will HIV treatment look like in the future?
Conference Home